Accolade (NASDAQ:ACCD) posted its quarterly earnings results on Wednesday. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.03, MarketWatch Earnings reports. The company had revenue of $38.44 million during the quarter, compared to the consensus estimate of $36.20 million. The firm’s quarterly revenue was up 29.7% compared to the same quarter last year.
ACCD opened at $49.67 on Friday. Accolade has a twelve month low of $28.68 and a twelve month high of $65.25. The company has a 50-day moving average of $50.48.
Several research firms have weighed in on ACCD. SVB Leerink lifted their price target on shares of Accolade from $44.00 to $53.00 and gave the company a “market perform” rating in a research note on Friday. Piper Sandler boosted their target price on shares of Accolade from $55.00 to $57.00 and gave the stock an “overweight” rating in a research report on Friday. Robert W. Baird boosted their target price on shares of Accolade from $45.00 to $50.00 and gave the stock an “outperform” rating in a research report on Friday. Morgan Stanley boosted their target price on shares of Accolade from $37.00 to $48.00 and gave the stock an “overweight” rating in a research report on Friday, October 16th. Finally, DA Davidson boosted their target price on shares of Accolade from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Thursday, October 15th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $50.08.
Accolade Company Profile
Accolade, Inc develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.
Recommended Story: Asset Allocation Models, Which is Right For You?
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.